Long-Lasting Relief
for Canine Urinary Incontinence
Mictamid®Mictamid® Hydrogel is a minimally invasive injectable solution designed to help veterinarians treat Urethral Sphincter Mechanism Incompetence (USMI) in dogs with urinary leakage.
Watch How the Treatment Works
What Is Canine USMI?
Urethral Sphincter Mechanism Incompetence, or USMI, is one of the most common causes of urinary incontinence in dogs.
It occurs when the urethral sphincter does not close tightly enough to prevent urine leakage. Dogs may leak urine while resting or sleeping, often without being aware of it. USMI is most frequently seen in spayed female dogs, but it can affect males as well.
Signs to Watch For
If a dog is experiencing urinary incontinence due to USMI, the signs are often subtle but consistent. Recognizing the symptoms early can help guide timely evaluation and treatment.
Urine Leakage at Rest
Dribbling or wet bedding, especially while the dog is sleeping, resting comfortably, or fully relaxed.
Frequent Dampness Around the Tail
Persistent moisture, mild skin irritation, or urine staining around the hindquarters and inner thighs.
Accidents Despite Normal Behavior
Urine leakage without signs of discomfort, straining, or noticeable changes in normal urination habits.omfort or changes in urination habits.
Not Sure If It’s USMI?
If your dog is showing signs of urinary incontinence, we’re here to help.
Contact us to learn more.
Contact Us
How Mictamid® Works
A minimally invasive approach designed to improve urethral closure and
reduce or eliminate urinary leakage in dogs with USMI.
Targeted Urethral Placement
Mictamid® is injected into the urethral submucosa under cystoscopic guidance using a standardized injection technique designed for reproducible results.
Forms Supportive Cushions
The homogeneous, non-particulate hydrogel forms soft-tissue cushions that support circumferential urethral coaptation and improve closure control.
2.5% Cross Linked Polyacrylamide
Mictamid® is comprised of 97.5% water and 2.5% cross linked polyacrylamide and is non-degradable, non-migratory, and non-toxic.
Advancing Confidence in Canine Continence Care
Our CommitmentMictamid® is designed to provide veterinarians with a reliable, minimally invasive solution for managing canine USMI. Our focus is on supporting better clinical outcomes through innovation, precision, and long term performance.
Our mission is to support veterinarians with reliable, minimally invasive solutions for managing canine urinary incontinence. Combining clinical precision, practical training, and consistent outcomes in everyday practice.
Our vision is to advance the standard of care for canine continence management through innovation, clinical collaboration, and solutions designed to improve outcomes for veterinary teams and patients.
Frequently Asked Questions
Clear answers to common questions about Mictamid® and the treatment of canine USMI.
Mictamid®The condition itself is not typically painful, though chronic moisture may cause skin irritation.
Mictamid is designed for long-term durability and multi-year continence improvement.
It is a minimally invasive cystoscopic injection performed under light sedation.
Discover how Mictamid® supports long-term improvements
in incontinence.
Discover how targeted urethral support can make a measurable difference.